CERTIFICATION OF

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Michelle Rico, the Chief Executive Officer and Chief Financial Officer of Proto Script Pharmaceutical Corp. (the “Company”), hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:


(i)	the Quarterly Report on Form 10-Q/A of the Company, for the fiscal quarter ended June 30, 2016, and to which this certification is attached as Exhibit 32.1 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(ii)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


	By:	/s/ Michelle Rico
	Name:	Michelle Rico
	Title:	Chief Executive Officer and
		Chief Financial Officer

	Date:	December 7, 2016

PROTO SCRIPT PHARMACEUTICAL CORP 10-Q/A